Jérémy Jové

Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, France

Poster(s):

• (A-357) Assessment of the Risk of 32 Adverse Effects of Special Interest following COVID-19 Vaccination in the Whole French Population
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-141) Comparative effectiveness of robot-assisted radical prostatectomy versus open radical prostatectomy: a high dimensional propensity score matched cohort study within a nationwide claims database
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-093) Preliminary results from a European post authorization study to assess the safety of Paxlovid among patients with moderate or severe hepatic or renal impairment
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-257) Preliminary Results from a European Post-Authorization Study to Assess the Safety of Paxlovid in Pregnancy
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-148) REpositioning of Medications IN Dementia (REMIND): Evaluating fitness for purpose of the SNDS French nationwide claims database
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-023) Studying paternal drug exposures and offspring outcomes: feasibility assessment of large European databases
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-210) Validation and improvement of an algorithm identifying relapses in multiple sclerosis (MS) within the French nationwide claims database
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET